Answer
Crovalimab specifically binds with high affinity to complement component C5, inhibiting its cleavage into C5a and C5b and thereby preventing formation of the membrane attack complex.
Sources for this answer
- PiaSky 340 mg solution for injection/infusionRoche Products Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked